LivingGLP1
Study S002137

Community Outreach Support and Engagement Using Online Strategies - Decentralized Insights Into Therapy Adoption and Value

Registration

Registration
NCT06761703
Acronym
COSMOS-DIGITAL
Study type
OBSERVATIONAL
Status
COMPLETED
Enrollment
200
Start
2024-11-14
Primary completion
2025-01-06
Lead sponsor
Amgen
Conditions
Obesity
Interventions
DEVICE:TAPĀ® Micro Select Device (Touch Activated Phlebotomy)
Results posted
FALSE
Individual participant data sharing
YES

Registered primary outcomes

  • Number of Participants with Self-blood Draw Received by Central Laboratory [30 days]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.